SCHEMBL9531409

SCHEMBL9531409

CCCc1c(C(F)F)n(CCC)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 7/20 0.42
AGTR2 P50052 7/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9035703 0.95 AGTR1 (0.46) AGTR1AGTR2
SCHEMBL9036452 0.95 AGTR1 (0.44) AGTR1AGTR2
SCHEMBL9035467 0.94 AGTR1 (0.45) AGTR1AGTR2
SCHEMBL9036009 0.94 AGTR1 (0.44) AGTR1AGTR2
SCHEMBL9036548 0.94 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9534527 0.94 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9036264 0.93 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL9036939 0.93 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL9530064 0.92 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL9035027 0.91 AGTR1 (0.46) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed